Valuation : CVRx, Inc.

Market Cap 81.26M 69.88M 65.73M 60M 112M 7.68B 113M 779M 301M 3.94B 305M 298M 12.54B P/E 2026 *
-1.51x
P/E 2027 * -1.6x
Enterprise Value 91.76M 78.91M 74.22M 67.75M 127M 8.68B 127M 880M 340M 4.44B 345M 337M 14.16B EV / Sales 2026 *
1.56x
EV / Sales 2027 * 1.88x
Free-Float
80.18%
Yield 2026 *
-
Yield 2027 * -
1 day+1.33%
1 week+3.04%
Current month+3.04%
1 month+27.62%
3 months-43.31%
6 months-63.03%
Current year-57.04%
1 week 2.96
Extreme 2.96
3.18
1 month 2.2
Extreme 2.2
3.42
Current year 2.2
Extreme 2.2
9.84
1 year 2.2
Extreme 2.2
11.3
3 years 2.2
Extreme 2.2
33.14
5 years 2.2
Extreme 2.2
33.14
10 years 2.2
Extreme 2.2
33.14
Manager TitleAgeSince
Chief Executive Officer 60 12/02/2024
Chief Operating Officer 57 11/08/2025
Chief Tech/Sci/R&D Officer 66 23/05/2024
Director TitleAgeSince
Director/Board Member 61 01/10/2008
Director/Board Member 57 01/07/2020
Director/Board Member 52 01/07/2020
Date Insider Type Main position Quantity % Market Cap. Importance
13/8/26 Buy

Chief Operating Officer

26,223 0.0988%
12/8/26 Sell

Chief Operating Officer

-1,309 0.0049%
1/6/26
Treo Ventures LLC
OtherCompany 0 0% -
Change 5-day change 1-year change 3-year change Capi.($)
+1.33%+3.04%-61.00%-81.13% 81.26M
+0.32%-0.29%+14.46%+11.27% 12.69B
-0.06%-0.25%+14.11%+30.54% 6.92B
-2.33%+14.93% - - 6.54B
-3.19%-12.75%+22.39%+12.67% 5.89B
-3.40%-0.93%-21.51%+49.41% 5.04B
-0.93%-1.66%-30.95%-21.24% 3.79B
+1.70%+1.64%+46.09%-10.30% 2.09B
-0.18%-6.10%-6.56%+117.97% 1.69B
-2.09%-4.39%+45.93%-18.01% 1.65B
Average -0.88%+0.02%+2.55%+10.13% 4.64B
Weighted average by Cap. -1.10%+0.44%+8.62%+18.54%

Financials

2026 *2027 *
Net sales 58.85M 50.61M 47.6M 43.46M 81.27M 5.57B 81.54M 564M 218M 2.85B 221M 216M 9.08B 66.18M 56.91M 53.53M 48.87M 91.39M 6.26B 91.69M 635M 245M 3.21B 249M 243M 10.21B
Net income -53.45M -45.97M -43.23M -39.47M -73.81M -5.06B -74.05M -513M -198M -2.59B -201M -196M -8.25B -52.14M -44.84M -42.17M -38.5M -72M -4.93B -72.23M -500M -193M -2.52B -196M -192M -8.04B
Net Debt 10.5M 9.03M 8.5M 7.76M 14.5M 993M 14.55M 101M 38.94M 509M 39.44M 38.58M 1.62B 42.94M 36.93M 34.73M 31.7M 59.29M 4.06B 59.49M 412M 159M 2.08B 161M 158M 6.62B
Logo CVRx, Inc.
CVRx, Inc. is a commercial-stage medical device company. The Company is focused on developing, manufacturing and commercializing advanced neuromodulation solutions for patients with cardiovascular diseases. The Company's integrated platform technology, Barostim, is designed to leverage the power of the brain and nervous system to address the imbalance of the autonomic nervous system (ANS), which causes heart failure with reduced ejection fraction (HFrEF) and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy (BAT) by sending imperceptible and persistent electrical pulses to baroreceptors located in the wall of the carotid artery to signal the brain to modulate cardiovascular function. Barostim is a minimally invasive neuromodulation device that consists of two implantable components, an implantable pulse generator (IPG) and a stimulation lead, and is programmed by a wireless clinician-controlled programmer that communicates with the IPG.
Employees
223
Date Price Change Volume
04/09/26 USD 3.050 +1.33% 856,028
03/09/26 USD 3.010 -1.95% 614,544
02/09/26 USD 3.070 +0.99% 530,032
01/09/26 USD 3.040 +2.70% 780,721
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
3.050USD
Average target price
4.583USD
Spread / Average Target
+50.27%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CVRX Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!